N2OFF (NITO) said Wednesday that it signed a definitive deal to acquire the biotech company MitoCareX Bio from owners Alon Silberman, Ciro Leonardo Pierri and SciSparc (SPRC)
Under the terms, N2OFF will purchase 4,961 MitoCareX shares from SciSparc for $700,000 and exchange additional shares with the all sellers for stock totaling 40% of its outstanding share capital.
N2OFF said the sellers will also be entitled to 30% of its financing proceeds, up to a maximum of $1.6 million, over five years and milestone-based issuances of up to 25% of its common shares.
MitoCareX will become a subsidiary of N2OFF after closing of the transaction, which remains subject to approval by N2OFF shareholders, the company said.
N2OFF shares were down more than 15% in recent trading Wednesday.
Price: 0.52, Change: -0.05, Percent Change: -9.41
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。